Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.55
Bid: 20.55
Ask: 21.25
Change: -1.45 (-6.59%)
Spread: 0.70 (3.406%)
Open: 22.00
High: 22.00
Low: 20.55
Prev. Close: 22.00
ALL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further Amendments To Long Term Retention Plan

26 Aug 2014 10:00

RNS Number : 9916P
Allocate Software PLC
26 August 2014
 



26 August 2014

 

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

 

Further amendments to Long Term Retention Plan ("LTRP")

 

Following the announcement on 21 July 2014, and subsequent discussions with the Company's major shareholders and Numis, the Board has decided to make a further amendment to the performance conditions of the LTRP awarded to Ian Bowles in December 2011.

 

Background

Under the terms of the LTRP, Ian Bowles was awarded in December 2011, 1,000,000 nil-price options over ordinary shares in the Company which would vest between September 2014 and September 2016 subject to (a) the Company's earnings per share increasing at or above a 15% annual compound growth rate; and (b) a demanding absolute total shareholder return ("TSR") against which options would vest on a sliding scale. 20% of the options will vest at a 15% annual compound TSR and the options would vest in full at or above a 25% annual compound TSR.

On 21 July 2014, the Company announced that three principal changes had been made to the LTRP. Firstly, the targets for TSR were changed from a range of 15% - 25% to a range of 7.5% - 15%. Secondly, instead of 20% of the shares vesting at the minimum level of TSR achievement, the proportion that would vest at this level would change to 70%. Finally the earnings per share target were changed to an annual compound growth rate of 5%.

 

Further amendments

 

Following consultation with the Company's major shareholders and Numis, the Board has decided to make the amendments set out below.

 

400,000 ordinary shares will remain subject to the amendments announced in July 2014, and will vest immediately.

 

300,000 ordinary shares will vest in September 2015 (the "2015 Options") and a further 300,000 ordinary shares in September 2016 (the "2016 Options"). The 2015 Options and the 2016 Options are subject to the following performance conditions:

 

(a) EPS condition

 

The first 50% of the shares under option will be subject to the EPS condition which will be based on a minimum of 7.5% annual compound growth and a maximum of 15% annual compound growth.

 

If the minimum of 7.5% EPS growth is achieved then 33% of the first 50% of the shares will vest, if the maximum of 15% EPS growth is achieved then 100% of the first 50% of the shares will vest.

 

Where the EPS growth is between 7.5% and 15% then the number of shares vesting will be on a straight line basis between 33% and 100%.

 

(b) TSR condition

 

The second 50% of the shares under option will be subject to the TSR condition which is based on a minimum of 7.5% annual compound growth in TSR and a maximum of 20% annual compound growth in TSR.

 

If the minimum of 7.5% TSR growth is achieved then 33% of the second 50% of the shares will vest, if the maximum of 20% TSR growth is achieved then 100% of the second 50% of the shares will vest.

 

Where the TSR growth is between 7.5% and 20% then the number of shares vesting will be on a straight line basis between 33% and 100%.

 

 

The EPS condition and the TSR condition will apply separately to 50% of the shares under each option. It is no longer necessary to satisfy both conditions for any part of the option to vest.

 

 

 

 

 

 

Enquiries:

 

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

 

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Simon Willis / Richard Thomas

Corporate Broking - James Black

 

Tel: +44 (0) 20 7260 1000

FTI Consulting

Matt Dixon, Chris Lane

Tel : +44 (0) 20 3727 1000

 

 

About Allocate Software plc

Allocate Software is the leading workforce and corporate governance software solutions provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include Healthcare and Defence.

 

The experience and in-depth knowledge gained in the UK and internationally has enabled Allocate to invest in developing innovative solutions that are relevant to the constantly evolving market needs of its customers. At the core of the business is Allocate's workforce optimisation software, which streamlines the whole workforce management of multi-disciplinary groups, across diverse locations.

 

Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

 

Allocate is quoted on the London Stock Exchange (AIM: ALL).

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEISWMFLSEIA
Date   Source Headline
24th Apr 20247:00 amRNSQuarterly Activities and Cash Flow Report
18th Apr 20247:00 amRNSExploration-focused Investor Webinar
16th Apr 20247:00 amRNSInvestor Presentation - Paydirt Battery Minerals
8th Apr 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFurther Broad and High-Grade Drill Intersections
15th Mar 20247:00 amRNSHalf-year Financial Report
27th Feb 20247:00 amRNSConference Attendance
15th Feb 20247:00 amRNSDirector/PDMR Dealings
5th Feb 20247:00 amRNSMultiple Broad and High-Grade Drill Intersections
2nd Feb 20247:00 amRNSConference Attendance – Mining Indaba
1st Feb 20248:20 amRNSInvestor Presentation - Investor Webinar
31st Jan 20247:00 amRNSQuarterly Activities and Cash Flow Report
29th Jan 20247:00 amRNSInvestor Webinar
25th Jan 20247:00 amRNSUpdate on Competitive Offtake Partnering Process
24th Jan 20247:00 amRNSCompletion of US$5m MIIF Subscription
23rd Jan 20247:00 amRNSTR-1 Notification of Major Holdings
2nd Jan 20247:00 amRNSCorporate Update - Director / PDMR Shareholding
29th Dec 20237:00 amRNSCorporate Update - Director / PDMR Shareholding
28th Dec 20237:00 amRNSGrant of PDMR Performance Rights
22nd Dec 20237:00 amRNSDirector / PDMR Dealings & Shareholding Update
21st Dec 20237:00 amRNSCorporate Update - Director / PDMR Dealings
20th Dec 20237:00 amRNSBoard Changes
15th Dec 20237:00 amRNSSuccessful Completion of A$8million Equity Placing
14th Dec 20234:45 pmRNSA$7 million Equity Placing
12th Dec 20237:00 amRNSMaiden Feldspar Mineral Resource Estimate
30th Nov 202311:57 amRNSAmended Constitution
30th Nov 202311:50 amRNSResult of Annual General Meeting
30th Nov 20237:02 amRNSAGM Statement
28th Nov 20237:00 amRNS106m Continuous Pegmatite Interval Reported
23rd Nov 20239:39 amRNSUpdated Quarterly Activities and Cash Flow Report
22nd Nov 20237:00 amRNSProject Development Update
16th Nov 20237:00 amRNSInvestor Presentation - Noosa Mining Conference
15th Nov 20237:00 amRNSRejection of Non-Binding Indicative Offers
14th Nov 20237:00 amRNSGrant of Highly Prospective Licences for Lithium
10th Nov 20237:00 amRNSConference Attendance
7th Nov 20237:00 amRNSAdditional Resource Extension Drilling Planned
1st Nov 20237:00 amRNSChange of Registered Office
31st Oct 20237:05 amRNSNotice of AGM
31st Oct 20237:00 amRNSQuarterly Activities and Cash Flow Report
20th Oct 20237:00 amRNSMining Lease Granted for Ewoyaa Lithium Project
19th Oct 202311:35 amRNSStatement re Media Speculation
13th Oct 20237:00 amRNSConference Attendance
10th Oct 20237:00 amRNSApproval to Divert Transmission Lines at Ewoyaa
29th Sep 20239:55 amRNSInvestor Presentation
28th Sep 20237:00 amRNS2023 Annual Financial Report
21st Sep 20237:00 amRNSNotice of Results and Investor Presentation
15th Sep 20237:00 amRNSConference Attendance
8th Sep 20237:05 amRNSInvestor Presentation
8th Sep 20237:00 amRNSUS$32.9m Strategic Investment
6th Sep 20237:00 amRNSResource and Exploration Drilling Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.